Key result
CorMatrix anterior leaflet augmentation for complex tricuspid valve repair resulted in a 73.8% survival rate at 2 years, with larger preoperative tethering area and distance predicting poor outcomes.
Why the study?
In some patients undergoing surgery for tricuspid regurgitation, anterior leaflet patch augmentation may be necessary to optimize tricuspid competence, prompting review of midterm and long-term center outcomes.
Does CorMatrix anterior leaflet augmentation provide stable repair and improve outcomes in patients with severe or moderate tricuspid regurgitation?
Cohort (n=19)
No
Does CorMatrix anterior leaflet augmentation provide stable repair and improve outcomes in patients with severe or moderate tricuspid regurgitation?
Answers are grounded in this paper and cite their sources.
CorMatrix anterior leaflet augmentation provides stable tricuspid valve repair in most patients, but significant preoperative tethering predicts poor outcomes, suggesting valve replacement may be preferable in those cases.
BACKGROUND: Tricuspid annuloplasty is the most common surgical approach to correct tricuspid regurgitation (TR). In some patients, however, anterior leaflet patch augmentation may be necessary to optimize tricuspid competence. We reviewed our center cohort over the midterm and long term. METHODS: From January 2013 to August 2018, 424 tricuspid valve procedures were performed, of which 420 were repairs and 4 were replacements. Indications were either isolated severe TR or moderate or greater TR, concomitant with other surgery. In the repair cohort, we identified those that had a patch augmentation, and the database was interrogated for preoperative characteristics. The resulting patients had outpatient assessment (clinical and echocardiography) at 6 weeks and at a later interval. Additionally, a comparison was made between those who had good and poor results (moderate or greater TR or cardiac death). RESULTS: In the repair cohort, 19 patients underwent complex tricuspid valve repair with CorMatrix anterior leaflet augmentation. Preoperative characteristics were as follows: age, 65.5 ± 13.5 years; New York Heart Association (NYHA) class, 3.5 ± 0.5; left ventricular ejection fraction, 48.3% ± 5.9%; tricuspid annular plane systolic excursion, 17.1 ± 3.7 mm; right ventricle (good, mild, moderate, poor), 10, 5, 4, 0; annulus size, 40.9 ± 6.9 mm; mean tethering distance, 1.00 ± 0.3 cm; and mean tethering area, 1.53 ± 1.16 cm2. Mean follow-up was 2.1 ± 1.9 years, and survival at 2 years was 73.8%. There were 2 in-hospital deaths. Mean NYHA class was 1.0 ± 0.5 (6 weeks) and 1.5 ± 0.6 (later follow-up); mean residual TR grade was 0.5 ± 0.6 (6 weeks) and 1.3 ± 1.4 (follow-up). Ten of 13 survivors had a good result at last follow-up (TR 0 to 1). We compared the preoperative and operative data of this group versus those with poor results (TR >1 or cardiac mortality). Significant univariate predictors of poor results were larger preoperative tethering area (1.18 ± 0.43 versus 2.4 ± 1.5 cm2; P = .02), longer tethering distance (0.87 ± 0.21 versus 1.2 ± 0.19 cm; P = .007), or the presence of mild or greater TR at 6 weeks (0.2 ± 0.4 vs 1.25 ± 0.5; P = .03). CONCLUSIONS: CorMatrix anterior leaflet augmentation produces successful, stable repair in the majority of this complex population. The presence of even mild TR at 6 weeks' follow-up predicts a poor result. When the tethering area or the tethering distance is significantly high, replacement is probably a better option.
No takes yet. Share an insight, caveat, or question.
Rescigno et al. (2021) conducted a cohort in Tricuspid regurgitation (n=19). CorMatrix anterior leaflet augmentation was evaluated on Survival at 2 years. CorMatrix anterior leaflet augmentation for complex tricuspid valve repair resulted in a 73.8% survival rate at 2 years, with larger preoperative tethering area and distance predicting poor outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: